1、 KUMAR-SINHA C,KALYANA-SUNDARAM S,CHINNAIYAN A M.Landscape of gene fusions in epithelial cancers:seq and ye shall find[J].Genome Med,2015(7):129. KUMAR-SINHA C,KALYANA-SUNDARAM S,CHINNAIYAN A M.Landscape of gene fusions in epithelial cancers:seq and ye shall find[J].Genome Med,2015(7):129.
2、 GROUP P T C,CALABRESE C,DAVIDSON N R,et al.Genomic basis for RNA alterations in cancer[J].Nature,2020,578(7793):129-136. GROUP P T C,CALABRESE C,DAVIDSON N R,et al.Genomic basis for RNA alterations in cancer[J].Nature,2020,578(7793):129-136.
3、 KURAVI S,CHENG J,FANGMAN G,et al.Preclinical evaluation of gilteritinib on NPM1-ALK-Driven anaplastic large cell lymphoma cells[J].Mol Cancer Res,2021,19(5):913-920. KURAVI S,CHENG J,FANGMAN G,et al.Preclinical evaluation of gilteritinib on NPM1-ALK-Driven anaplastic large cell lymphoma cells[J].Mol Cancer Res,2021,19(5):913-920.
4、 SHAW A T,YEAP B Y,SOLOMON B J,et al.Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement:a retrospective analysis[J].Lancet Oncol,2011,12(11):1004-1012. SHAW A T,YEAP B Y,SOLOMON B J,et al.Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement:a retrospective analysis[J].Lancet Oncol,2011,12(11):1004-1012.
5、 BARWICK B G,ABRAMOVITZ M,KODANI M,et al.Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts[J].Br J Cancer,2010,102(3):570-576. BARWICK B G,ABRAMOVITZ M,KODANI M,et al.Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts[J].Br J Cancer,2010,102(3):570-576.
6、 VITALE S R,RUIGROK-RITSTIER K,TIMMERMANS A M,et al.The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer[J].BMC Cancer,2022,22(1):165. VITALE S R,RUIGROK-RITSTIER K,TIMMERMANS A M,et al.The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer[J].BMC Cancer,2022,22(1):165.
7、 GUO W,ZHU Y,PU X,et al.Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma[J].Front Oncol,2023(13):1116648. GUO W,ZHU Y,PU X,et al.Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma[J].Front Oncol,2023(13):1116648.
8、 ROSSI V,LEVATI L,BIONDI A.Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR[J].Methods Mol Med,2006(125):115-126. ROSSI V,LEVATI L,BIONDI A.Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR[J].Methods Mol Med,2006(125):115-126.
9、 RIGGI N,SUVA M L,STAMENKOVIC I.Ewing's Sarcoma[J].N Engl J Med,2021,384(2):154-164. RIGGI N,SUVA M L,STAMENKOVIC I.Ewing's Sarcoma[J].N Engl J Med,2021,384(2):154-164.
10、 YANG Z,YU L,WANG Z.PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer[J].Chin J Cancer Res,2016,28(1):65-71. YANG Z,YU L,WANG Z.PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer[J].Chin J Cancer Res,2016,28(1):65-71.
11、 JABBOUR E,KANTARJIAN H.Chronic myeloid leukemia:2022 update on diagnosis,therapy,and monitoring[J].Am J Hematol,2022,97(9):1236-1256. JABBOUR E,KANTARJIAN H.Chronic myeloid leukemia:2022 update on diagnosis,therapy,and monitoring[J].Am J Hematol,2022,97(9):1236-1256.
12、 SELVANATHAN S P,GRAHAM G T,ERKIZAN H V,et al.Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing[J].Proc Natl Acad Sci U S A,2015,112(11):E1307-16. SELVANATHAN S P,GRAHAM G T,ERKIZAN H V,et al.Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing[J].Proc Natl Acad Sci U S A,2015,112(11):E1307-16.
13、 MANI R S,IYER M K,CAO Q,et al.TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers[J].Cancer Res,2011,71(16):5387-5392. MANI R S,IYER M K,CAO Q,et al.TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers[J].Cancer Res,2011,71(16):5387-5392.
14、 REJESKI K,DUQUE-AFONSO J,LUBBERT M.AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms[J].Oncogene,2021,40(38):5665-5676. REJESKI K,DUQUE-AFONSO J,LUBBERT M.AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms[J].Oncogene,2021,40(38):5665-5676.
15、 MAZZU Y Z,LIAO Y,NANDAKUMAR S,et al.Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity[J].Mol Oncol,2022,16(13):2451-2469. MAZZU Y Z,LIAO Y,NANDAKUMAR S,et al.Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity[J].Mol Oncol,2022,16(13):2451-2469.
16、 CAI C,WANG H,HE H H,et al.ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer[J].J Clin Invest,2013,123(3):1109-1122. CAI C,WANG H,HE H H,et al.ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer[J].J Clin Invest,2013,123(3):1109-1122.
17、 LINARDIC C M.PAX3-FOXO1 fusion gene in rhabdomyosarcoma[J].Cancer Lett,2008,270(1):10-18. LINARDIC C M.PAX3-FOXO1 fusion gene in rhabdomyosarcoma[J].Cancer Lett,2008,270(1):10-18.
18、 SINGH S,ABU-ZAID A,JIN H,et al.Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma[J].Sci Transl Med,2022,14(653):eabq2096. SINGH S,ABU-ZAID A,JIN H,et al.Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma[J].Sci Transl Med,2022,14(653):eabq2096.
19、 ELSHATLAWY M,SAMPSON J,CLARKE K,et al.EML4-ALK biology and drug resistance in non-small cell lung cancer:a new phase of discoveries[J].Mol Oncol,2023,17(6):950-963. ELSHATLAWY M,SAMPSON J,CLARKE K,et al.EML4-ALK biology and drug resistance in non-small cell lung cancer:a new phase of discoveries[J].Mol Oncol,2023,17(6):950-963.
20、 SHARMA N,MAGISTRONI V,PIAZZA R,et al.BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene[J].Mol Cancer,2015(14):132. SHARMA N,MAGISTRONI V,PIAZZA R,et al.BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene[J].Mol Cancer,2015(14):132.
21、 JAIN S,ABRAHAM A.BCR-ABL1-like B-Acute lymphoblastic leukemia/lymphoma:A comprehensive review[J].Arch Pathol Lab Med,2020,144(2):150-155. JAIN S,ABRAHAM A.BCR-ABL1-like B-Acute lymphoblastic leukemia/lymphoma:A comprehensive review[J].Arch Pathol Lab Med,2020,144(2):150-155.
22、 LIQUORI A,IBANEZ M,SARGAS C,et al.Acute promyelocytic leukemia:A constellation of molecular events around a single PML-RARA fusion gene[J].cancers(Basel),2020,12(3):624. LIQUORI A,IBANEZ M,SARGAS C,et al.Acute promyelocytic leukemia:A constellation of molecular events around a single PML-RARA fusion gene[J].cancers(Basel),2020,12(3):624.
23、 GORTHI A,ROMERO J C,LORANC E,et al.EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma[J].Nature,2018,555(7696):387-391. GORTHI A,ROMERO J C,LORANC E,et al.EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma[J].Nature,2018,555(7696):387-391.
24、 BRAUN T P,EIDE C A,DRUKER B J.Response and resistance to BCR-ABL1-targeted therapies[J].cancer cell,2020,37(4):530-542. BRAUN T P,EIDE C A,DRUKER B J.Response and resistance to BCR-ABL1-targeted therapies[J].cancer cell,2020,37(4):530-542.
25、 WANG Z,GUAN W,WANG M,et al.AML1-ETO inhibits acute myeloid leukemia immune escape by CD48[J].Leuk Lymphoma,2021,62(4):937-943. WANG Z,GUAN W,WANG M,et al.AML1-ETO inhibits acute myeloid leukemia immune escape by CD48[J].Leuk Lymphoma,2021,62(4):937-943.
26、 DELLIAUX C,TIAN T V,BOUCHET M,et al.TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases[J].Cancer Lett,2018(438):32-43. DELLIAUX C,TIAN T V,BOUCHET M,et al.TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases[J].Cancer Lett,2018(438):32-43.
27、 DAMAYANTI N P,BUDKA J A,KHELLA H W Z,et al.Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma[J].Clin Cancer Res,2018,24(23):5977-5989. DAMAYANTI N P,BUDKA J A,KHELLA H W Z,et al.Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma[J].Clin Cancer Res,2018,24(23):5977-5989.
28、 NECKLES C,SUNDARA RAJAN S,CAPLEN N J.Fusion transcripts:Unexploited vulnerabilities in cancer?[J].Wiley Interdiscip Rev RNA,2020,11(1):e1562. NECKLES C,SUNDARA RAJAN S,CAPLEN N J.Fusion transcripts:Unexploited vulnerabilities in cancer?[J].Wiley Interdiscip Rev RNA,2020,11(1):e1562.
29、 MUKHERJEE S,MUKHERJEE S B,FRENKEL-MORGENSTERN M.Functional and regulatory impact of chimeric RNAs in human normal and cancer cells[J].Wiley Interdiscip Rev RNA,2023,14(5):e1777. MUKHERJEE S,MUKHERJEE S B,FRENKEL-MORGENSTERN M.Functional and regulatory impact of chimeric RNAs in human normal and cancer cells[J].Wiley Interdiscip Rev RNA,2023,14(5):e1777.
30、 CHENG Y W,CHEN Y M,ZHAO Q Q,et al.Long read single-molecule real-time sequencing elucidates transcriptome-wide heterogeneity and complexity in esophageal squamous cells[J].Front Genet,2019(10):915. CHENG Y W,CHEN Y M,ZHAO Q Q,et al.Long read single-molecule real-time sequencing elucidates transcriptome-wide heterogeneity and complexity in esophageal squamous cells[J].Front Genet,2019(10):915.
31、 STANGL C,DE BLANK S,RENKENS I,et al.Partner independent fusion gene detection by multiplexed CRISPR-Cas9 enrichment and long read nanopore sequencing[J].Nat Commun,2020,11(1):2861. STANGL C,DE BLANK S,RENKENS I,et al.Partner independent fusion gene detection by multiplexed CRISPR-Cas9 enrichment and long read nanopore sequencing[J].Nat Commun,2020,11(1):2861.
32、 LI Z,QIN F,LI H.Chimeric RNAs and their implications in cancer[J].Curr Opin Genet Dev,2018(48):36-43. LI Z,QIN F,LI H.Chimeric RNAs and their implications in cancer[J].Curr Opin Genet Dev,2018(48):36-43.
33、 DORNEY R,DHUNGEL B P,RASKO J E J,et al.Recent advances in cancer fusion transcript detection[J].Brief Bioinform,2023,24(1):bbac 519. DORNEY R,DHUNGEL B P,RASKO J E J,et al.Recent advances in cancer fusion transcript detection[J].Brief Bioinform,2023,24(1):bbac 519.
34、 WANG Y,ZOU Q,LI F,et al.Identification of the cross-strand chimeric RNAs generated by fusions of bi-directional transcripts[J].Nat Commun,2021,12(1):4645. WANG Y,ZOU Q,LI F,et al.Identification of the cross-strand chimeric RNAs generated by fusions of bi-directional transcripts[J].Nat Commun,2021,12(1):4645.
35、 LI H,WANG J,MA X,et al.Gene fusions and RNA trans-splicing in normal and neoplastic human cells[J].Cell Cycle2009,8(2):218-222. LI H,WANG J,MA X,et al.Gene fusions and RNA trans-splicing in normal and neoplastic human cells[J].Cell Cycle2009,8(2):218-222.
36、 PRAKASH T,SHARMA V K,ADATI N,et al.Expression of conjoined genes:another mechanism for gene regulation in eukaryotes[J].PLoS One,2010,5(10):e13284. PRAKASH T,SHARMA V K,ADATI N,et al.Expression of conjoined genes:another mechanism for gene regulation in eukaryotes[J].PLoS One,2010,5(10):e13284.
37、 NACU S,YUAN W,KAN Z,et al.Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples[J].BMC Med Genomics,2011(4):11. NACU S,YUAN W,KAN Z,et al.Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples[J].BMC Med Genomics,2011(4):11.
38、 LEI Q,LI C,ZUO Z,et al.Evolutionary insights into RNA trans-splicing in vertebrates[J].Genome Biol Evol,2016,8(3):562-577. LEI Q,LI C,ZUO Z,et al.Evolutionary insights into RNA trans-splicing in vertebrates[J].Genome Biol Evol,2016,8(3):562-577.
39、 SINGH D,CHAN J M,ZOPPOLI P,et al.Transforming fusions of FGFR and TACC genes in human glioblastoma[J].Science,2012,337(6099):1231-1235. SINGH D,CHAN J M,ZOPPOLI P,et al.Transforming fusions of FGFR and TACC genes in human glioblastoma[J].Science,2012,337(6099):1231-1235.
40、 LU G,WU J,ZHAO G,et al.Abundant and broad expression of transcription-induced chimeras and protein products in mammalian genomes[J].Biochem Biophys Res Commun,2016,470(3):759-765. LU G,WU J,ZHAO G,et al.Abundant and broad expression of transcription-induced chimeras and protein products in mammalian genomes[J].Biochem Biophys Res Commun,2016,470(3):759-765.
41、 ZOMA M,CURTI L,SHINDE D,et al.EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer[J].Nat Commun,2021,12(1):4147. ZOMA M,CURTI L,SHINDE D,et al.EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer[J].Nat Commun,2021,12(1):4147.
42、 KO J M,CHEUNG M H,KWAN M W,et al.Genomic instability and alterations in Apc,Mcc and Dcc in Hong Kong patients with colorectal carcinoma[J].Int J Cancer,1999,84(4):404-409. KO J M,CHEUNG M H,KWAN M W,et al.Genomic instability and alterations in Apc,Mcc and Dcc in Hong Kong patients with colorectal carcinoma[J].Int J Cancer,1999,84(4):404-409.
43、 XIAO S,NALABOLU S R,ASTER J C,et al.FGFR1 is fused with a novel zinc-finger gene,ZNF198,in the t(8;13)leukaemia/lymphoma syndrome[J].Nat Genet,1998,18(1):84-87. XIAO S,NALABOLU S R,ASTER J C,et al.FGFR1 is fused with a novel zinc-finger gene,ZNF198,in the t(8;13)leukaemia/lymphoma syndrome[J].Nat Genet,1998,18(1):84-87.
44、 SODA M,CHOI Y L,ENOMOTO M,et al.Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer[J].Nature,2007,448(7153):561-566. SODA M,CHOI Y L,ENOMOTO M,et al.Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer[J].Nature,2007,448(7153):561-566.
45、 RABBITTS T H.Chromosomal translocations in human cancer[J].Nature,1994,372(6502):143-149. RABBITTS T H.Chromosomal translocations in human cancer[J].Nature,1994,372(6502):143-149.
46、 BOER J M,DEN BOER M L.BCR-ABL1-like acute lymphoblastic leukaemia:From bench to bedside[J].Eur J Cancer,2017(82):203-218. BOER J M,DEN BOER M L.BCR-ABL1-like acute lymphoblastic leukaemia:From bench to bedside[J].Eur J Cancer,2017(82):203-218.
47、 SHOSHANI O,BRUNNER S F,YAEGER R,et al.Chromothripsis drives the evolution of gene amplification in cancer[J].Nature,2021,591(7848):137-141. SHOSHANI O,BRUNNER S F,YAEGER R,et al.Chromothripsis drives the evolution of gene amplification in cancer[J].Nature,2021,591(7848):137-141.
48、 SUN Y,LI H.Chimeric RNAs discovered by RNA sequencing and their roles in cancer and rare genetic diseases[J].Genes(Basel),2022,13(5):741. SUN Y,LI H.Chimeric RNAs discovered by RNA sequencing and their roles in cancer and rare genetic diseases[J].Genes(Basel),2022,13(5):741.
49、 DAI X,THEOBARD R,CHENG H,et al.Fusion genes:A promising tool combating against cancer[J].Biochim Biophys Acta Rev Cancer,2018,1869(2):149-160. DAI X,THEOBARD R,CHENG H,et al.Fusion genes:A promising tool combating against cancer[J].Biochim Biophys Acta Rev Cancer,2018,1869(2):149-160.
50、 ZHANG Y,GONG M,YUAN H,et al.Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation[J].Cancer Discov,2012,2(7):598-607. ZHANG Y,GONG M,YUAN H,et al.Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation[J].Cancer Discov,2012,2(7):598-607.
51、 PANAGOPOULOS I,HEIM S.Neoplasia-associated chromosome translocations resulting in gene truncation[J].Cancer Genomics Proteomics,2022,19(6):647-672. PANAGOPOULOS I,HEIM S.Neoplasia-associated chromosome translocations resulting in gene truncation[J].Cancer Genomics Proteomics,2022,19(6):647-672.
52、 CORTES J E,GAMBACORTI-PASSERINI C,DEININGER M W,et al.Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia:results from the randomized BFORE trial[J].J Clin Oncol,2018,36(3):231-237. CORTES J E,GAMBACORTI-PASSERINI C,DEININGER M W,et al.Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia:results from the randomized BFORE trial[J].J Clin Oncol,2018,36(3):231-237.
53、 CHWALENIA K,FACEMIRE L,LI H.Chimeric RNAs in cancer and normal physiology[J].Wiley Interdiscip Rev RNA,2017,8(6). CHWALENIA K,FACEMIRE L,LI H.Chimeric RNAs in cancer and normal physiology[J].Wiley Interdiscip Rev RNA,2017,8(6).
54、 WU H,LI X,LI H.Gene fusions and chimeric RNAs,and their implications in cancer[J].Genes Dis,2019,6(4):385-390. WU H,LI X,LI H.Gene fusions and chimeric RNAs,and their implications in cancer[J].Genes Dis,2019,6(4):385-390.
55、 AKIVA P,TOPORIK A,EDELHEIT S,et al.Transcription-mediated gene fusion in the human genome[J].Genome Res,2006,16(1):30-36. AKIVA P,TOPORIK A,EDELHEIT S,et al.Transcription-mediated gene fusion in the human genome[J].Genome Res,2006,16(1):30-36.
56、 XIE Z Q,BABICEANU M,KUMAR S,et al.Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma[J].PNatl Acad Sci USA,2016,113(46):13126-13131. XIE Z Q,BABICEANU M,KUMAR S,et al.Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma[J].PNatl Acad Sci USA,2016,113(46):13126-13131.
57、 LI W,GUO L,LIU Y,et al.Potential unreliability of uncommon ALK,ROS1,and RET genomic breakpoints in predicting the efficacy of targeted Therapy in NSCLC[J].J Thorac Oncol,2021,16(3):404-418. LI W,GUO L,LIU Y,et al.Potential unreliability of uncommon ALK,ROS1,and RET genomic breakpoints in predicting the efficacy of targeted Therapy in NSCLC[J].J Thorac Oncol,2021,16(3):404-418.
58、 KOHSAKA S,HAYASHI T,NAGANO M,et al.Identification of novel CD74-NRG2alpha fusion from comprehensive profiling of lung adenocarcinoma in Japanese never or light smokers[J].J Thorac Oncol,2020,15(6):948-961. KOHSAKA S,HAYASHI T,NAGANO M,et al.Identification of novel CD74-NRG2alpha fusion from comprehensive profiling of lung adenocarcinoma in Japanese never or light smokers[J].J Thorac Oncol,2020,15(6):948-961.
59、 HANAHAN D.Hallmarks of Cancer:New Dimensions[J].Cancer Discov,2022,12(1):31-46. HANAHAN D.Hallmarks of Cancer:New Dimensions[J].Cancer Discov,2022,12(1):31-46.
